Chapter 1. Introduction -- Chapter 2. Who is (still) smoking? -- Chapter 3. E-cigarettes: the technology, the market, and the practice of vaping -- Chapter 4. Is vaping safe? -- Chapter 5. E-cigarettes and smoking cessation -- Chapter 6. The polarization over e-cigarettes -- Chapter 7. E-cigarette regulations and why they fail -- Chapter 8.Towards optimal e-cigarette policy -- Chapter 9. Remaining Questions -- Chapter 10. Conclusion.

The first volume of this three-volume resource presents a historical analysis of the practice of smoking, the rise and fall of the cigarette market, and the successes and failures of tobacco control. While taxes, regulations, and various behavioral and pharmacological interventions have helped many people to quit smoking, they have not helped everyone. The authors explain why these strategies alone are likely insufficient to elicit smoking cessation among the remaining group, and why “ramping up” these strategies may also backfire. Drawing on examples from the U.S., Australia, Canada, and the United Kingdom, this volume introduces the technology of e-cigarettes, explaining the origins of the innovation, patterns of use among consumers, and the perception of e-cigarettes among key stakeholder groups. Samuel C. Hampsher-Monk is Managing Director of BOTEC Analysis, where he leads research on the regulation of tobacco, cannabis, and reduced-risk nicotine products for public and private clients, including 501(c)(3) groups and LLPs, as well as municipal and state regulators. He holds a BA in Politics and Philosophy from the University of Southampton and a MSc from the University of Edinburgh. James E. Prieger, an economist, is Professor of Public Policy at Pepperdine University and Senior Researcher at BOTEC Analysis, where he leads research on illicit tobacco markets, alternative nicotine products, and related policy issues.He has published over 50 peer-reviewed journal articles and chapters. He received his BA from Yale University and his PhD in economics from the University of California, Berkeley. Sudhanshu Patwardhan is a medical doctor, working on tobacco harm reduction projects globally. He has worked in R&D in the pharma and tobacco sectors across three continents. Patwardhan qualified as a doctor from BJ Medical College Pune,India, received a Master of Business and Science from the Keck Graduate Institute,California, USA, and holds an MBA from the London Business School, UK.